Nvidias Blockbuster Earnings Highlight 200 Billion Edge Computing Opportunity as China Market Fades
Enterprise Products Partners EPD Receives Higher Price Target Amid Mixed Analyst Sentiment
Mint and Rice Robotics Joint Venture Aims to Expand AI Companion Robot Business with HK15M Funding
SPIC Reports Higher Q4 Profit on Improved Cost Management FullYear Net Income Rises
Grayscale Identifies Four Altcoins Poised to Benefit From the CLARITY Act
ASML Holding NV Deepens India Presence Through Tata Electronics Partnership
Bridgeline Digital Q1 2026 Earnings EPS Misses Estimates Amidst Significant Surprise
Utah Medical Products Inc UTMD Q1 2024 Earnings EPS of 109 Reported Stock Gains Modestly
TLPH Q1 2026 Earnings Significant EPS Beat as PreRevenue Biotech Advances Pipeline
Boyd Gaming BYD Q1 2026 Earnings EPS Misses Estimates Amid Challenging Operating Environment
TrioTech International TRT Q3 2024 Earnings Modest Profit Reported Amidst Challenging Environment
Werewolf Therapeutics HOWL Q1 2026 Earnings NarrowerthanExpected Loss Highlights Operational Discipline
Flutter Entertainment FLUT Slides 18 as Selling Pressure Tests Key Support Levels
Tvardi Therapeutics TVRD Holds Steady Near Support Amid LowVolume Trading
Zscaler Plunges Over 31 Key Support and Resistance Levels for ZS Stock
Alpha Pro Tech Ltd APT Gains Ground as Technical Levels Come into Focus
SEATW Holds Steady at 006 Amid Minimal Activity Vivid Seats Warrant Remains RangeBound
Trump Seeks Supreme Court Intervention to Delay TikTok Ban
CCLD Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines
BranchOut Food Inc BOF Surges 4 as Buyers Test Key Resistance at 345
Alcon Inc Ordinary Shares ALC Q1 2026 Earnings EPS Beat Drives Optimism but Stock Edges Lower
Bioventus BVS Q1 2026 Earnings Strong EPS Beat Amidst Market Skepticism
VC Q1 2026 Earnings EPS Beat Surprises Market Shares Jump 29
NetSTREIT Corp NTST Q1 2026 Earnings EPS Misses Street View Shares Dip on Weaker Profitability
WNC Q1 2026 Earnings EPS Misses Estimates Amid Persistent Headwinds
AIM ImmunoTech Q1 2026 Earnings EPS Miss Widens as Clinical Pipeline Drives Higher Operating Costs
ET Q1 2026 Earnings Earnings Miss Expectations as Margin Pressures Persist